Exenatide Protects Against Cardiac Dysfunction by Attenuating Oxidative Stress in the Diabetic Mouse Heart

Cardiovascular disease is the major cause of death in patients with diabetes. Current treatment strategies for diabetes rely on lifestyle changes and glucose control to prevent angiopathy and organ failure. Exenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is used as an add-on therapy t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Wei, Chang, Wen-guang, Guo, Xiao-ci, Liu, Ying, Xiao, Dan-dan, Ding, Dan, Wang, Jian-xun, Zhang, Xue-juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459897/
https://www.ncbi.nlm.nih.gov/pubmed/31024445
http://dx.doi.org/10.3389/fendo.2019.00202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459897/
https://www.ncbi.nlm.nih.gov/pubmed/31024445
http://dx.doi.org/10.3389/fendo.2019.00202

Ejemplares similares